'Critical gaps' in breast cancer research

October 3, 2013
'Critical gaps' in breast cancer research

Critical gaps in breast cancer research could see the loss of around 185,000* lives by 2030 if they are not urgently addressed, according to a major new study co-authored by researchers from King's College London.

Globally, is the most frequently diagnosed cancer in , with an estimated 1.38 million new cases per year. 50,000 cases in women and 400 in men are recorded each year in the UK alone.

Published today by Breast Cancer Campaign, the research brought together more than 100 internationally recognised scientists, clinicians and healthcare professionals, along with patient advocates, to explore which gaps in research, if filled, would bring the greatest patient benefits.

The gaps range from identifying lifestyle changes which could enable women to protect themselves from the disease to a better understanding of how tumours grow and spread to other parts of the body.

Some of the gaps concern the need for new treatments – particularly for secondary or , where the tumour spreads to other parts of the body. There is a need for biopsies, ortissue samples, to be taken from these secondary cancers, because they are often not the same as the primary cancer, according to the researchers.

Further research is needed to understand what it is that enables to become resistant to drugs and to spread throughout the body.

A better understanding of prevention is also required to identify which sustainable changes in lifestyle, such as diet and exercise, can reduce a woman's chance of developing cancer in the first place.

Explore further: Breast cancer research highlights gaps

More information: breast-cancer-research.com/content/15/5/R92

Related Stories

Breast cancer research highlights gaps

October 2, 2013
(Medical Xpress)—Research involving a Newcastle University academic has identified the ten critical gaps that exist in breast cancer research, which if not urgently addressed could see the loss of around 185,000 lives by ...

FDA approves first pre-surgical breast cancer drug

September 30, 2013
Federal health officials say they have approved a biotech drug from Roche as the first medicine labeled for the treatment of breast cancer before surgery.

Alternative target for breast cancer drugs

July 19, 2013
Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Scientists find promising new target for aggressive breast cancer

March 20, 2013
Women with triple-negative breast cancer are more likely to have high levels of the MET biomarker in their tumours, making it a good new target for cancer drugs according to research published in the British Journal of Cancer, ...

Fragile X syndrome protein linked to breast cancer progression

September 18, 2013
A research team led by scientists from VIB/KU Leuven, Belgium, and the University of Rome Tor Vergata, Italy, in collaboration with several research centers and hospitals in Italy, the United Kingdom and, Belgium, has identified ...

First in-depth study of secondary breast cancer patients finds current care inadequate

July 31, 2013
A qualitative study following the experiences of 10 women living with secondary breast cancer in the UK has identified evidence of poor care for this much overlooked group.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.